GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poxel SA (OTCPK:PXXLF) » Definitions » Financial Strength

Poxel (PXXLF) Financial Strength : 1 (As of Dec. 2022)


View and export this data going back to 2016. Start your Free Trial

What is Poxel Financial Strength?

Poxel has the Financial Strength Rank of 1. It displays poor financial strength and is likely in financial distress. Usually this is caused by too much debt for the company.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.

Poxel did not have earnings to cover the interest expense. Poxel's debt to revenue ratio for the quarter that ended in Dec. 2022 was 36.75. As of today, Poxel's Altman Z-Score is 0.00.


Competitive Comparison of Poxel's Financial Strength

For the Biotechnology subindustry, Poxel's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Poxel's Financial Strength Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poxel's Financial Strength distribution charts can be found below:

* The bar in red indicates where Poxel's Financial Strength falls into.



Poxel Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Poxel's Interest Expense for the months ended in Dec. 2022 was $-2.39 Mil. Its Operating Income for the months ended in Dec. 2022 was $-10.29 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was $26.71 Mil.

Poxel's Interest Coverage for the quarter that ended in Dec. 2022 is

Poxel did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

Poxel's Debt to Revenue Ratio for the quarter that ended in Dec. 2022 is

Debt to Revenue Ratio=Total Debt (Q: Dec. 2022 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(19.302 + 26.714) / 1.252
=36.75

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Poxel has a Z-score of 0.00, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Poxel  (OTCPK:PXXLF) Financial Strength Explanation

The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.

Poxel has the Financial Strength Rank of 1. It displays poor financial strength and is likely in financial distress. Usually this is caused by too much debt for the company.


Poxel Financial Strength Related Terms

Thank you for viewing the detailed overview of Poxel's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


Poxel (PXXLF) Business Description

Traded in Other Exchanges
Address
259/261 Avenue Jean Jaures, Immeuble le Sunway, Lyon, FRA, 69007
Poxel SA is a biopharmaceutical company. It is focused on the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as nonalcoholic steatohepatitis (NASH) and rare disorders (ALD/AMN). It has developed a portfolio of drug candidates, including its candidates: Imeglimin, for the treatment of type 2 diabetes, and PXL770 and PXL065, for the treatment of NASH.

Poxel (PXXLF) Headlines

From GuruFocus

Full Year 2018 Poxel SA Earnings Call Transcript

By GuruFocus Research 03-02-2024

Half Year 2023 Poxel SA Earnings Call Transcript

By GuruFocus Research 03-02-2024

Poxel SA - Special Call Transcript

By GuruFocus Research 03-02-2024

Full Year 2020 Poxel SA Earnings Call Transcript

By GuruFocus Research 03-02-2024

Half Year 2020 Poxel SA Earnings Call Transcript

By GuruFocus Research 03-02-2024

Half Year 2022 Poxel SA Earnings Call Transcript

By GuruFocus Research 03-02-2024

Poxel S.A. - Special Call Transcript

By GuruFocus Research 03-02-2024

Half Year 2019 Poxel SA Earnings Call Transcript

By GuruFocus Research 03-02-2024

Half Year 2021 Poxel SA Earnings Call(English) Transcript

By GuruFocus Research 03-02-2024